Janosek, J., Hilscherova, K., Blaha, L
Among 11 meta-analyses, 4 did not report primary studies
fine stratification weights were estimated according to Desai and colleagues.12 We calculated standardised differences to assess balance of baseline characteristics between groups, with a difference below 10% considered consistent with good balance
In the ever-evolving landscape of weight-loss medications, semaglutide has emerged as a groundbreaking option
Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
These conversations are easier to have before a pregnancy is underway than after, and they ensure that both the benefits and risks of tirzepatide are managed thoughtfully across the full reproductive picture